Codexis (CDXS) Competitor Comparison
We are evaluating the key criteria listed to compare Codexis (CDXS) against its competitors in the Biotechnology industry.
Market Capitalization
205 / 368Gross Profits
88 / 278Total Revenue
105 / 300EBITDA
148 / 337Free Cashflow
94 / 352Quick Ratio
275 / 357Earnings per Share
114 / 359Dividend yield
0 / 6Total Cash
237 / 358Performance 3 years
296 / 368Performance 5 years
220 / 368Performance 10 years
76 / 368Linearity 3 years
305 / 368Linearity 5 years
131 / 368Linearity 10 years
17 / 368Total Rank
88 / 368Dividend Rank
91 / 368Valuation Rank
166 / 368Piotroski Rank
98 / 368Muliplier Rank
90 / 368Market Capitalization - CDXS ranking 205 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.